GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC (XPAE:PHARMACARE) » Definitions » ROCE %

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) ROCE % : -2.07% (As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2021 was -2.07%.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals ROCE % Historical Data

The historical data trend for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals ROCE % Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.88 7.38 -1.90 8.00 7.91

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 19.27 5.86 - -2.07

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals ROCE % Calculation

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=3.907/( ( (64.657 - 16.997) + (72.316 - 21.177) )/ 2 )
=3.907/( (47.66+51.139)/ 2 )
=3.907/49.3995
=7.91 %

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2021 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2021 )  (Q: Sep. 2021 )(Q: Dec. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2021 )  (Q: Sep. 2021 )(Q: Dec. 2021 )
=-1.136/( ( (70.208 - 11.833) + (72.316 - 21.177) )/ 2 )
=-1.136/( ( 58.375 + 51.139 )/ 2 )
=-1.136/54.757
=-2.07 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2021) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals  (XPAE:PHARMACARE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 677, Ramallah, PSE
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC is engaged in the manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Headlines

No Headlines